Ding Li, Gong Bin, Chu Xiaoxiang, Hu Jingjing, Zheng Hen
Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
J Pharm Biomed Anal. 2007 Jun 28;44(2):526-31. doi: 10.1016/j.jpba.2007.01.041. Epub 2007 Feb 2.
A sensitive method, based on liquid chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS), was developed for the determination of trimetazidine in human plasma. Buflomedil was used as the internal standard (IS). Plasma samples were extracted with a mixture of cyclohexane-diethyl ether (1:1, v/v) and the analytes were chromatographically separated on a phenomenex Luna 5 mu C18 (2) 100A HPLC column with a mobile phase of 10 mM ammonium acetate buffer solution containing 0.1% acetic acid-methanol (45:55, v/v). The electrospray ionization was employed in a single quadrupole mass spectrometer for the analytical determination. The lower limit of quantification (LLOQ) was 0.5 ng/ml for trimetazidine and the measuring ranges were from 0.5 to 200 ng/ml. The intra- and inter-run standard deviation was less than 4.1% and 7.8%, respectively. The method was successfully applied to study the pharmacokinetics of trimetazidine in healthy Chinese volunteers.
建立了一种基于液相色谱 - 电喷雾电离 - 质谱联用(LC - ESI - MS)的灵敏方法,用于测定人血浆中的曲美他嗪。将丁咯地尔用作内标(IS)。血浆样品用环己烷 - 乙醚(1:1,v/v)混合物萃取,分析物在phenomenex Luna 5μm C18(2) 100A高效液相色谱柱上进行色谱分离,流动相为含0.1%乙酸的10 mM醋酸铵缓冲溶液 - 甲醇(45:55,v/v)。在单四极杆质谱仪中采用电喷雾电离进行分析测定。曲美他嗪的定量下限(LLOQ)为0.5 ng/ml,测量范围为0.5至200 ng/ml。批内和批间标准偏差分别小于4.1%和7.8%。该方法成功应用于研究曲美他嗪在健康中国志愿者体内的药代动力学。